26
Apr 10
Pharmaceutical company Hospira Inc. have decided to increase their pain management portfolio by combining with Javelin Pharmaceuticals for $145m.
Javelin will get paid $2.20 a share which averages it out at $145m.
The two companies agreed that Javelin can be lent up to amount of $4.5m to help with managing activities before finalising a merger with Hospira.